Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
托泊苷或者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不或继发性白血病的发生迹象。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
托泊苷或者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不或继发性白血病的发生迹象。
声明:以上例、词性类均由互联网资源自动生成,经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。